---
document_datetime: 2024-09-10 15:55:01
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/bimzelx-epar-all-authorised-presentations_en.pdf
document_name: bimzelx-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.7286065
conversion_datetime: 2025-12-14 22:33:40.484258
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form              | Route of Administration   | Immediate Packaging                           | Content (concentration)   | Pack size                                 |
|------------------|-------------------|------------|----------------------------------|---------------------------|-----------------------------------------------|---------------------------|-------------------------------------------|
| EU/1/21/1575/001 | Bimzelx           | 160 mg     | Solution for injection           | Subcutaneous use          | pre-filled syringe (glass)                    | 1 ml (160 mg/ml)          | 1 pre-filled syringe                      |
| EU/1/21/1575/002 | Bimzelx           | 160 mg     | Solution for injection           | Subcutaneous use          | pre-filled syringe (glass)                    | 1 ml (160 mg/ml)          | 2 pre-filled syringes                     |
| EU/1/21/1575/003 | Bimzelx           | 160 mg     | Solution for injection           | Subcutaneous use          | pre-filled syringe (glass)                    | 1 ml (160 mg/ml)          | 3 (3 x 1) pre-filled syringes (multipack) |
| EU/1/21/1575/004 | Bimzelx           | 160 mg     | Solution for injection           | Subcutaneous use          | pre-filled syringe (glass)                    | 1 ml (160 mg/ml)          | 4 (2 x 2) pre-filled syringes (multipack) |
| EU/1/21/1575/005 | Bimzelx           | 160 mg     | Solution for injection           | Subcutaneous use          | pre-filled syringe (glass) in pre- filled pen | 1 ml (160 mg/ml)          | 1 pre-filled pen                          |
| EU/1/21/1575/006 | Bimzelx           | 160 mg     | Solution for injection           | Subcutaneous use          | pre-filled syringe (glass) in pre- filled pen | 1 ml (160 mg/ml)          | 2 pre-filled pens                         |
| EU/1/21/1575/007 | Bimzelx           | 160 mg     | Solution for injection           | Subcutaneous use          | pre-filled syringe (glass) in pre- filled pen | 1 ml (160 mg/ml)          | 3 (3 x 1) pre-filled pens (multipack)     |
| EU/1/21/1575/008 | Bimzelx           | 160 mg     | Solution for injection           | Subcutaneous use          | pre-filled syringe (glass) in pre- filled pen | 1 ml (160 mg/ml)          | 4 (2 x 2) pre-filled pens (multipack)     |
| EU/1/21/1575/009 | Bimzelx           | 320 mg     | Solution for                     | Subcutaneous use          | pre-filled syringe (glass)                    | 2 ml (160 mg/ml)          | 1 pre-filled syringe                      |
| EU/1/21/1575/010 | Bimzelx           | 320 mg     | injection Solution for injection | Subcutaneous use          | pre-filled syringe (glass)                    | 2 ml (160 mg/ml)          | 3 (3 x 1) pre-filled syringes (multipack) |
| EU/1/21/1575/011 | Bimzelx           | 320 mg     | Solution for injection           | Subcutaneous use          | pre-filled syringe (glass) in pre- filled pen | 2 ml (160 mg/ml)          | 1 pre-filled pen                          |
| EU/1/21/1575/012 | Bimzelx           | 320 mg     | Solution for injection           | Subcutaneous use          | pre-filled syringe (glass) in pre- filled pen | 2 ml (160 mg/ml)          | 3 (3 x 1) pre-filled pens (multipack)     |